<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137908">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01943981</url>
  </required_header>
  <id_info>
    <org_study_id>OC13OISI0099</org_study_id>
    <nct_id>NCT01943981</nct_id>
  </id_info>
  <brief_title>Exercise Performance in Patients With Atrial Fibrillation</brief_title>
  <acronym>AF-CPX</acronym>
  <official_title>Exercise Performance in Patients With Atrial Fibrillation: Usefulness of Cardiopulmonary Exercise Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Incheon St.Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Incheon St.Mary's Hospital</source>
  <oversight_info>
    <authority>Korea (the Republic of): the Clinical Research Cordinating Center (CRCC) of the Catholic University Center</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure and stroke are the two major complication of atrial fibrillation. Current
      treatment for atrial fibrillation is so focused to stroke prevention, but the risk
      assessment for heart failure is less highlighted. The most of patients with atrial
      fibrillation have cardiac functional limitation of variable degree. We hypothesize that the
      exercise test would reveal the subclinical cardiac dysfunction, and might be helpful to
      classify the patients with atrial fibrillation according to their exercise capacity real
      cardiac function.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Exercise response patterns of heart rate and oxygen uptake</measure>
    <time_frame>At baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite cardiovascular events (all death, admission of heart failure, stroke/thromboembolism)</measure>
    <time_frame>Up to 2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Optimal/inappropriate exercise response</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial fibrillation and preserved left ventricular systolic function
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nonvalvular chronic atrial fibrillation

          -  Left ventricular ejection fraction &gt;40%

        Exclusion Criteria:

          -  Acute decompensated heart failure within 30 days

          -  unstable hemodynamic status

          -  Significant coronary artery disease

          -  Any condition interfering sufficient exercise

          -  Valvular stenosis or regurgitation of moderate or severe degree

          -  Obstructive or restrictive lung disease of moderate or severe degree

          -  Active malignancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Incheon St.Mary's Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>403-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kim</last_name>
      <phone>82322805163</phone>
      <email>mjkim@catholic.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Kim</last_name>
      <email>heart3162@hanmail.net</email>
    </contact_backup>
    <investigator>
      <last_name>Mi-Jeong Kim, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Doo Soo Jeon, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 12, 2013</lastchanged_date>
  <firstreceived_date>September 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Incheon St.Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Mi-Jeong Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
